NASDAQ
IGC Pharma, Inc. (IGC) has a revenue compound annual growth rate of -20.77% over 5 years and -16.46% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.